Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS DIVIS LABORATORIES IPCA LABS/
DIVIS LABORATORIES
 
P/E (TTM) x 48.7 67.3 72.4% View Chart
P/BV x 5.1 7.3 69.5% View Chart
Dividend Yield % 0.3 0.9 40.1%  

Financials

 IPCA LABS   DIVIS LABORATORIES
EQUITY SHARE DATA
    IPCA LABS
Mar-23
DIVIS LABORATORIES
Mar-23
IPCA LABS/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0624,641 22.9%   
Low Rs7682,730 28.1%   
Sales per share (Unadj.) Rs243.0292.6 83.0%  
Earnings per share (Unadj.) Rs19.468.7 28.2%  
Cash flow per share (Unadj.) Rs29.781.6 36.4%  
Dividends per share (Unadj.) Rs4.0030.00 13.3%  
Avg Dividend yield %0.40.8 53.7%  
Book value per share (Unadj.) Rs230.3480.9 47.9%  
Shares outstanding (eoy) m253.70265.47 95.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.812.6 29.9%   
Avg P/E ratio x47.253.7 87.9%  
P/CF ratio (eoy) x30.845.2 68.2%  
Price / Book Value ratio x4.07.7 51.8%  
Dividend payout %20.643.7 47.2%   
Avg Mkt Cap Rs m232,120978,378 23.7%   
No. of employees `000NANA-   
Total wages/salary Rs m12,8769,750 132.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64277,675 79.4%  
Other income Rs m1,5183,447 44.0%   
Total revenues Rs m63,16081,122 77.9%   
Gross profit Rs m9,03323,691 38.1%  
Depreciation Rs m2,6163,432 76.2%   
Interest Rs m48220 2,458.7%   
Profit before tax Rs m7,45323,686 31.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5345,453 46.5%   
Profit after tax Rs m4,91918,234 27.0%  
Gross profit margin %14.730.5 48.0%  
Effective tax rate %34.023.0 147.7%   
Net profit margin %8.023.5 34.0%  
BALANCE SHEET DATA
Current assets Rs m51,89397,437 53.3%   
Current liabilities Rs m18,05815,331 117.8%   
Net working cap to sales %54.9105.7 51.9%  
Current ratio x2.96.4 45.2%  
Inventory Days Days518 611.4%  
Debtors Days Days6842 0.7%  
Net fixed assets Rs m34,33651,128 67.2%   
Share capital Rs m254531 47.8%   
"Free" reserves Rs m58,167127,140 45.7%   
Net worth Rs m58,420127,671 45.8%   
Long term debt Rs m6,5180-   
Total assets Rs m86,229148,565 58.0%  
Interest coverage x16.51,209.5 1.4%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.70.5 136.7%   
Return on assets %6.312.3 51.0%  
Return on equity %8.414.3 59.0%  
Return on capital %12.218.6 65.8%  
Exports to sales %42.985.7 50.1%   
Imports to sales %13.319.8 67.0%   
Exports (fob) Rs m26,43466,537 39.7%   
Imports (cif) Rs m8,17815,378 53.2%   
Fx inflow Rs m26,43466,537 39.7%   
Fx outflow Rs m8,17815,715 52.0%   
Net fx Rs m18,25750,822 35.9%   
CASH FLOW
From Operations Rs m8,05824,597 32.8%  
From Investments Rs m-7,250-27,076 26.8%  
From Financial Activity Rs m5,072-7,972 -63.6%  
Net Cashflow Rs m5,881-10,451 -56.3%  

Share Holding

Indian Promoters % 46.3 51.9 89.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.8 36.7 121.9%  
FIIs % 10.3 14.9 69.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 48.1 111.7%  
Shareholders   82,809 354,482 23.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    SUPRIYA LIFESCIENCE     


More on IPCA Labs vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Divis Laboratories Share Price Performance

Period IPCA Labs Divis Laboratories S&P BSE HEALTHCARE
1-Day 0.11% 0.55% 0.88%
1-Month -4.98% -5.87% -4.09%
1-Year 49.28% 25.22% 59.00%
3-Year CAGR 7.72% 2.33% 18.97%
5-Year CAGR 21.22% 15.69% 19.20%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.